Please login to the form below

Not currently logged in
Email:
Password:

PharmaPros re-brands as eClinical Insights

US cloud-based clinical software firm says change coincides with industry trends

Clinical trial technology company PharmaPros has changed its name to eClinical Insights to better align itself with industry trends.

The Cambridge, Massachusetts-based firm says the switch also reflects its transition from a technology-enabled services organisation to a software-as-a-service (SaaS) outfit.

President and CEO Peg Regan said: “The transition into eClinical Insights has been a natural evolution, and has coincided with industry trends. After a decade of running clinical trials for customers, and leveraging our technology to provide best-of-breed solutions, we had a unique vantage point from which to develop software that enabled real-time collaboration and process improvement.

“Recognising the impact of global expansion, increased outsourcing, and continued adoption of electronic data capture technologies was having on trial visibility, we saw an opportunity to address these challenges through a technology platform that delivers process automation, data visualisation, and business analytics through the cloud.” 

The company's technology allows clinical trials to be managed across disparate teams, vendors, and clinical systems, and optimises collaboration between sponsors and contract research organisations (CROs).

“The outsourced clinical trials landscape has significantly reduced the sponsor company's control over the performance of their trials. As a result, CROs are being asked to provide metrics, KPIs, and trending on trial progress,” explained Regan.

“Our technology empowers CROs to deliver this mission critical information in real-time, and provides sponsor companies the ability to make critical business decisions using the most current and accurate information possible."

25th November 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics